Enbrel Market Potential
Executive Summary
Rheumatological Disorders Indication........... RA failures US Market Potential.. 350,000 Indication........... Juvenile RA US Market Potential.. 50,000 Indication........... First line use RA US Market Potential.. 590,000 Indication........... Psoriatic arthritis - severe US Market Potential.. 250,00 Indication........... Wegener's granulomatosis US Market Potential.. 50,000 Indication........... Ankylosis, spondylitis, etc. US Market Potential.. 50,000 Indication........... Total reumatological disorders US Market Potential.. 1.34 mil.